These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32112805)

  • 1. Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity.
    Ye D; Bao Z; Yu Y; Han Z; Yu Y; Xu Z; Ma W; Yuan Y; Zhang L; Xu Y; Ma T; Liu S; Gao X; Yan G; Huang Q; Wang X; Hua B; Yang F; Li Y; Cai B
    Toxicology; 2020 Apr; 435():152422. PubMed ID: 32112805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide blocked proliferation and cardiomyocyte differentiation of human induced pluripotent stem cells: Implication in cardiac developmental toxicity.
    Bao Z; Han Z; Zhang B; Yu Y; Xu Z; Ma W; Ding F; Zhang L; Yu M; Liu S; Jin M; Yan G; Huang Q; Wang X; Hua B; Yang F; Li Y; Liu Y; Zagidullin N; Carvalho K; Li B; Wang N; Cai B
    Toxicol Lett; 2019 Jul; 309():51-58. PubMed ID: 30946857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBL1 Is a Human Long Noncoding RNA that Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1.
    Liu J; Li Y; Lin B; Sheng Y; Yang L
    Dev Cell; 2017 Aug; 42(4):333-348.e5. PubMed ID: 28829943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin and CHIR99021 Coordinate Robust Cardiomyocyte Differentiation From Human Pluripotent Stem Cells Via Reducing p53-Dependent Apoptosis.
    Qiu XX; Liu Y; Zhang YF; Guan YN; Jia QQ; Wang C; Liang H; Li YQ; Yang HT; Qin YW; Huang S; Zhao XX; Jing Q
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2.
    Bylund JB; Trinh LT; Awgulewitsch CP; Paik DT; Jetter C; Jha R; Zhang J; Nolan K; Xu C; Thompson TB; Kamp TJ; Hatzopoulos AK
    Stem Cells Dev; 2017 May; 26(9):678-693. PubMed ID: 28125926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
    Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
    Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies.
    Konala VBR; Nandakumar S; Surendran H; Datar S; Bhonde R; Pal R
    Toxicol Appl Pharmacol; 2021 Dec; 433():115792. PubMed ID: 34742744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin triggers bioenergetic failure and p53 activation in mouse stem cell-derived cardiomyocytes.
    Cunha-Oliveira T; Ferreira LL; Coelho AR; Deus CM; Oliveira PJ
    Toxicol Appl Pharmacol; 2018 Jun; 348():1-13. PubMed ID: 29653124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired ROS Scavenging System in Human Induced Pluripotent Stem Cells Generated from Patients with MERRF Syndrome.
    Chou SJ; Tseng WL; Chen CT; Lai YF; Chien CS; Chang YL; Lee HC; Wei YH; Chiou SH
    Sci Rep; 2016 Mar; 6():23661. PubMed ID: 27025901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage-specific Effects of Bioactive Lipids on Human iPSC Cardiac Differentiation and Cardiomyocyte Proliferation.
    Sharma A; Zhang Y; Buikema JW; Serpooshan V; Chirikian O; Kosaric N; Churko JM; Dzilic E; Shieh A; Burridge PW; Wu JC; Wu SM
    Sci Rep; 2018 Apr; 8(1):6618. PubMed ID: 29700394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival.
    Jara-Avaca M; Kempf H; Rückert M; Robles-Diaz D; Franke A; de la Roche J; Fischer M; Malan D; Sasse P; Solodenko W; Dräger G; Kirschning A; Martin U; Zweigerdt R
    Stem Cell Reports; 2017 Feb; 8(2):305-317. PubMed ID: 28089668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-parameter in vitro screen in human stem cell-derived cardiomyocytes identifies ponatinib-induced structural and functional cardiac toxicity.
    Talbert DR; Doherty KR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Sci; 2015 Jan; 143(1):147-55. PubMed ID: 25304212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized conditions for the supplementation of human-induced pluripotent stem cell cultures with a GSK-3 inhibitor during embryoid body formation with the aim of inducing differentiation into mesodermal and cardiac lineage.
    Yoda K; Ohnuki Y; Masui S; Kurosawa H
    J Biosci Bioeng; 2020 Mar; 129(3):371-378. PubMed ID: 31615734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic DNA-binding inhibitor of SOX2 guides human induced pluripotent stem cells to differentiate into mesoderm.
    Taniguchi J; Pandian GN; Hidaka T; Hashiya K; Bando T; Kim KK; Sugiyama H
    Nucleic Acids Res; 2017 Sep; 45(16):9219-9228. PubMed ID: 28934500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP/TEAD3 signal mediates cardiac lineage commitment of human-induced pluripotent stem cells.
    Han Z; Yu Y; Cai B; Xu Z; Bao Z; Zhang Y; Bamba D; Ma W; Gao X; Yuan Y; Zhang L; Yu M; Liu S; Yan G; Jin M; Huang Q; Wang X; Hua B; Yang F; Pan Z; Liang H; Liu Y
    J Cell Physiol; 2020 Mar; 235(3):2753-2760. PubMed ID: 31541452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long non-coding RNA GATA6-AS1 adjacent to GATA6 is required for cardiomyocyte differentiation from human pluripotent stem cells.
    Jha R; Li D; Wu Q; Ferguson KE; Forghani P; Gibson GC; Xu C
    FASEB J; 2020 Nov; 34(11):14336-14352. PubMed ID: 32888237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission.
    Canfield SG; Zaja I; Godshaw B; Twaroski D; Bai X; Bosnjak ZJ
    Anesth Analg; 2016 May; 122(5):1269-79. PubMed ID: 26991754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a small molecule that promotes cell cycle activation of human induced pluripotent stem cell-derived cardiomyocytes.
    Ito M; Hara H; Takeda N; Naito AT; Nomura S; Kondo M; Hata Y; Uchiyama M; Morita H; Komuro I
    J Mol Cell Cardiol; 2019 Mar; 128():90-95. PubMed ID: 30684499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of growth factors on human induced pluripotent stem cells differentiation into cardiomyocytes.
    Yassa ME; Mansour IA; Sewelam NI; Hamza H; Gaafar T
    Life Sci; 2018 Mar; 196():38-47. PubMed ID: 29337067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.